← All indications
Abortion, Spontaneous
Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.
Subtype terms (6)
More specific conditions that are subtypes of Abortion, Spontaneous in the MeSH hierarchy.
- Abortion, Habitual
34 drugs (27 approved, 7 experimental)
- Abortion, Incomplete
3 drugs (2 approved, 1 experimental)
- Abortion, Missed
13 drugs (10 approved, 3 experimental)
- Abortion, Septic
3 drugs approved
- Abortion, Veterinary
- Embryo Loss
2 drugs approved
Drugs by status
Approved for this indication (4)
Phase 4 trials (13)
Phase 3 trials (3)
Phase 2 trials (7)
Organizations
Organization Involved with Phase 4 Indications (20)
- Center for Human Reproduction
- Ain Shams University
- Cairo University
- Federal University of Rio Grande do Sul
- Mansoura University
- University of Florence
- University of Khartoum
- University of Milan
- University of Toronto
- Assiut University
- Create Fertility Center
- Fudan University
- University of Copenhagen
- Zhejiang University
- Jiao Tong University
- University of Ferrara
- Free University of Brussels
- Foundation for Human Reproduction
- Aswan University
- Tongji University
Organization Involved with Phase 3 Indications (33)
- Abbott
- Kobe University
- Japan Blood Products Organization
- National Institutes of Health (NIH)
- University of Pennsylvania
- Benha University
- City Hospitals Sunderland NHS Foundation Trust
- University of London
- University of Eastern Finland
- University of Edinburgh
- University of Leeds
- University of Liverpool
- University of Manchester
- University of Melbourne
- University of Nottingham
- University of Oulu
- University of Tampere
- University of Toyama
- University of Birmingham
- University of Warwick
- Chinese University of Hong Kong
- University of California, Davis
- University of California, San Diego
- University of Turku
- University of Western Brittany
- The University of Hong Kong
- University of Oxford
- University of Paris
- Ben Gurion University
- Moorgreen Hospital, Southampton
- +3 more
Organization Involved with Phase 2 Indications (14)
- Biosearch S.A.
- Iltoo Pharma
- Nora Therapeutics, Inc.
- Allegiance Health
- Duke University
- McGill University
- Universidad Complutense de Madrid
- University of Utah
- Tabriz Medical University
- Canadian Institutes of Health Research (CIHR)
- Assistance Publique - Hôpitaux de Paris
- Hôpital Saint Antoine - PARIS
- Islamabad Medical and Dental College
- Centro de Diagnóstico Médico. Ayuntamiento de Madrid.
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (33)
- Grifols
- Pfizer
- Bayer
- Region Skane
- Boston University
- Helse Møre og Romsdal HF
- Hawler Medical University
- Northwestern University
- Norwegian University of Science and Technology
- Stanford University
- Sykehuset Innlandet HF
- The Hospital of Vestfold
- University of Iowa
- University of Tennessee
- University of Bergen
- University of British Columbia
- University of Chicago
- University of Colorado, Denver
- Uppsala University
- University of Haifa
- Karolinska Institute
- Nordland Hospital
- State University of New York, Buffalo
- University of Kuopio
- Kuopio University Hospital
- The Commonwealth Medical College
- Telemark Hospital Trust
- University of Iceland
- Vestre Viken Ringerike Sykehus
- Ferring
- +3 more